Parenteral Packaging Market Size, Share, and Trends 2024 to 2033

Parenteral Packaging Market Size and Growth

The global parenteral packaging market size was USD 31.98 billion in 2023, calculated at USD 33.93 billion in 2024 and is expected to reach around USD 57.71 billion by 2033, expanding at a CAGR of 6.08% from 2024 to 2033. The rising demand for pharmaceutical products across the world is driving the growth of the parenteral packaging market.

Parenteral Packaging Market Key Takeaways

• North America led the market with the largest share in 2023.
• Asia-Pacific is expected to attain the fastest rate of growth during the forecast period.
• By product type, the bottles segment is expected to be the fastest-growing segment during the forecast period.
• By drug type, the small molecules segment dominated the market in 2023.
• By drug type, the biologics segment is expected to grow with the highest CAGR during the forecast period.
• By material, the glass segment held a significant share in 2023 and is expected to grow with the fastest CAGR during the forecast period.
• By packaging type, the small volume parenteral segment dominated the market in 2023.
• By packaging type, the large volume parenteral segment is expected to grow with the fastest growth rate during the forecast period.

Market Overview

The parenteral packaging industry is one of the most important industries of the packaging industry. This industry mainly deals with developing storage solutions for medicinal items and pharma-based products. Several types of products are used in parenteral packaging, mainly bottles, ampoules, vials, prefilled syringes, cartridges, and others. The drugs that are stored in parenteral packaging mainly include small molecules, biologics, vaccines, biosimilars, and others. The parenteral packaging industry requires several materials, such as glass, polymer, PVC, and others. It mainly consists of two packaging types that mainly include small-volume parenteral and large-volume parenteral. This industry is expected to grow exponentially with the growth in the healthcare and biopharmaceutical industry.

• In January 2024, SGD Pharma inaugurated a new siliconization vials production plant in Quentin Lamotte, France. This new facility is opened to manage the demand and supply chain of parenteral packaging products across France.

Parenteral Packaging Market Growth Factors

• The growing developments in the healthcare sector are expected to drive the growth of the parenteral packaging market.
• The rising government initiatives for strengthening the pharmaceutical industry have driven the market growth.
• The increasing number of patients suffering from chronic diseases across the world fosters market growth.
• The growing investments from public and private sector entities in developing superior-quality parenteral packaging products propel the market's growth.
• The rising demand for injectables across the world boosts the market growth to some extent.
• The increasing number of vaccination programs around the world is expected to boost market growth.
• The rising advancements in pharma packaging technologies across the world boost market growth.
• The ongoing research and development activities related to the production of prefilled syringes, cartridges, and ready-to-use containers have positively impacted the market's growth.
• The rising use of vials to store liquids, powders, capsules, and other products worldwide is driving the market's growth.
• The growing advancements in the biopharmaceutical sector around the globe have boosted the market growth.

Parenteral Packaging Market Scope

Parenteral Packaging Market Dynamics

Driver

Rising cases of chronic disorders increase the demand for injectables

The number of chronic diseases such as cancer, chronic obstructive pulmonary disease (COPD), and others has increased rapidly in recent times. According to a Journal of Medical Internet Research, 80% of adults above 75 years or over suffered from multiple chronic diseases, and 90% of them suffered from at least one chronic disease. The prevalence of cancer has increased globally, which mainly includes carcinoma, melanoma, lymphoma, sarcoma, and leukemia, which increases the demand for injections for getting cured, thereby driving the market growth.

Also, the prevalence of cardiovascular diseases among patients has also increased rapidly around the globe, which has increased the demand for vaccines and drugs for treatment, which in turn increases the demand for parenteral packaging, thereby driving market growth. Moreover, the rising cases of obesity and diabetes among patients, along with the rising cases of accidents around the world, increases the demand for various types of injections for treating these health conditions, which in turn is expected to drive the growth of the parenteral packaging market.

• According to the World Health Organisation (WHO), the number of new cancer patients reached 20 million in 2022, along with 9.7 million cancer-related deaths in the same year (2022).
• According to the European Society of Cardiology, the world's population will be 8 billion in 2023, of which about 620 million people will have heart and circulatory diseases. 
• According to IDF Diabetes Atlas, the number of diabetes patients is expected to reach 643 million by 2030 and 783 million by 2045.
• According to a report published by the World Health Organisation (WHO) in December 2023, around 1.19 million people around the world die due to cases of road accidents.
• According to a report published by the World Health Organisation (WHO), more than 1 billion people around the world were suffering from obesity in 2022.

Restraint

High manufacturing cost

The application of parenteral packaging is very important in the storage of therapeutics and injections. Although the usage of parental packaging in the pharmaceutical industry is worth mentioning, the problems associated with the prices of raw materials and the rising labor charges in this industry are highly notable. This, in turn, increases the overall manufacturing cost of packaging. Thus, the high cost associated with the manufacturing of parenteral packaging is expected to restrain the growth of the parenteral packaging industry.

Opportunity

Integration of AI in parenteral packaging

The applications of AI have increased rapidly in the fields of labeling and packaging of oral doses and injections due to its ability to provide accurate labeling and a superior level of packaging associated with it. Recently, the integration of AI has been done in parenteral packaging to get superior outcomes and increase the authenticity of the product among consumers. Thus, the growing integration of AI technology in parenteral packaging activities is expected to create ample growth opportunities for market players in the coming days.

• In April 2023, Sea Vision Group launched an AI solution that can increase the performance of pharmaceutical packaging.

Product Insights

The bottles segment is expected to be the fastest-growing segment during the forecast period. The demand for plastic bottles has increased for storing various types of syrups due to their unbreakability and high-temperature resistance ability, driving market growth. Moreover, the growing application of glass bottles for storing medicines that contain strong acids and bases, along with their ability to protect against harmful ultraviolet rays, is likely to boost the growth of the parenteral packaging market.

• In January 2024, Loop Industries announced a partnership with Bormioli. This partnership is done to launch a new pharmaceutical bottle from 100% recycled virgin-quality Loop polyethylene terephthalate (PET) resin.

Drug Insights

The small molecules segment dominated the market in 2023 and is expected to continue its dominance during the forecast period. The demand for molecules-based medicines has increased due to the rise in the number of cancer patients across the world, which in turn increases the demand for parenteral packaging for storing these medicines, thereby driving market growth. In January 2024, BridGene Biosciences collaborated with Galapagos. This collaboration is being done to develop small molecule-based drugs for cancer treatment.

The biologics segment is expected to grow with the highest CAGR during the forecast period. The growing cases of psoriasis, rheumatoid arthritis (RA), and bowel diseases across the world have increased the demand for biologics medication, which in turn increases the demand for packaging of these medications, thereby driving the growth of the parenteral packaging market. In July 2023, Biocon Biologics launched Hulia. Hulia is a biological injection that is used to treat rheumatoid arthritis and psoriatic arthritis in the U.S. region.

Material Insights

The glass segment held the dominant share in 2023 and is expected to grow with the fastest CAGR during the forecast period. The growing demand for glass-based bottles, ampoules, vials, prefilled syringes, cartridges, and some other equipment for storing medicines has boosted the market growth. Moreover, glass-based parenteral packaging comes with several advantages, such as chemical stability and inertness for the packaging of medicines and injectables, which has boosted the growth of the parenteral packaging market. Also, glass-based storage solutions can withstand high temperatures and are mostly hydrolytic resistant, which makes them suitable for storing a wide range of medicines, thereby driving the market growth. Additionally, several companies are launching glass-based parenteral packaging products, which in turn has propelled the market growth.

• In March 2022, SGD Pharma announced a partnership with Stevanato Group. This partnership is done to launch a 100ml glass vial solution for the storage of high-value parenteral drugs.

Packaging Insights

The small-volume segment dominated the market in 2023. The rising applications of small-volume parenteral solutions, ranging from oral drops and otic to vaccinations and local anesthetics for treating patients suffering from various diseases, are likely to drive the growth of the parenteral packaging market.

• In April 2024, Upperton Pharma Solutions announced the inauguration of a new manufacturing facility in Nottingham, UK. This new facility will manufacture parenteral packaging solutions, including small-volume parenterals.

The large volume segment is expected to grow with the highest CAGR during the forecast period. The growing number of patients suffering from cholera has increased the demand for large-volume parenteral solutions, thereby driving market growth. Moreover, the rising use of large-volume parenteral solutions for correcting organic dysfunction, such as acid-based or saline balance for drug administration in the human body, is likely to boost the growth of the parenteral packaging market.

• In October 2023, Zacros launched the MediTect flexible packaging that includes large-volume parenterals. This packaging solution has been launched to store sensitive parenteral material and acts as an alternative to glass bottles.

Regional Insights

North America held the largest market share in 2023. The growth of the market in the North American region is mainly driven by the rising government investment in countries such as the U.S., Canada, Mexico, and some others for developing the healthcare sector. The rising developments in the biopharma sector, along with advancements in technologies related to packaging solutions, are driving the market growth in this region. Also, there are several research institutes related to the research and development of parenteral packaging solutions, which in turn has driven the market growth.

Moreover, the rising cases of cancer among patients increases the demand for effective injectables for treatment, which in turn increases the demand for parenteral packaging, thereby driving the market growth in this region. Moreover, several local market players, such as Becton, Dickinson and Company, Berry Global Inc., Baxter International Inc., and some others, are constantly engaged in developing parenteral packaging solutions and adopting strategies such as launches, joint ventures and business expansions, which in turn drives the growth of the parenteral packaging market in this region.

• According to the Canadian Cancer Statistics 2023, around 1 in 4 Canadian people is expected to die from cancer every year. It also estimated that cancer-related deaths in men are slightly more than females in Canada
• In March 2022, Nevakar Injectables Inc. launched ready-to-use ephedrine injection vials in the U.S. region.
• According to the Canadian Medical Association, the government of Canada invested around US$344 billion in the development of the healthcare sector in 2023, which is around 12.1% of the country's total GDP.

Asia Pacific is expected to be the fastest-growing region during the forecast period. The growing number of pharmacies and medical shops has boosted the market growth. Also, rising investments by new startup companies for manufacturing ampoules, vials, prefilled syringes, cartridges, and other packaging products, along with growing development in the biopharmaceutical industry in India, Japan, China, Singapore, and others, is driving the market growth. Also, the governments of several countries, such as India, China, Japan, and others, have increased their emphasis on developing the pharmaceutical industries, which in turn drives market growth.

• For instance, the Indian government launched a PLI scheme with an investment of Rs 15000 crores to develop the pharmaceutical industry from 2020 to 2029. Moreover, several local companies, such as Terumo Corporation, Nipro Corporation, Wuxi STA, and some others, are constantly engaged in developing parenteral packaging solutions and adopting strategies such as launches, joint ventures, and business expansions, which in turn drives the growth of the parenteral packaging market in this region.
• In December 2022, WuXi STA announced the inauguration of a new parenteral formulation manufacturing facility in Wuxi City, China. This facility is opened to enhance its packaging facility for both oral and injectable formulations.

Recent Developments

• In June 2024, Alcami made an announcement stating that it will be expanding its two new parenteral manufacturing facilities in South Carolina and North Carolina to maintain the demand and supply chain of parenteral storage products across the North American region.
• In October 2023, Zacros launched the MediTect flexible packaging. This packaging solution has been launched to store sensitive parenteral material and acts as an alternative to glass bottles.
• In October 2023, Gerresheimer launched the COP (Cyclic Olefin Polymer) vials. These vials are suitable for storing mRNA active ingredients at -80°C and cryogenic temperatures.
• In October 2023, Schott Pharma launched FIOLAX Pro. FIOLAX Pro is a next-generation type I borosilicate glass tubing that is used for the production of high-quality ampoules, vials, syringes, or cartridges for storing simple and complex drugs.
• In August 2023, Corning Inc. launched Corning Viridian Vials. This launch is done to expand Corning’s pharmaceutical glass-packaging portfolio.

Parenteral Packaging Market Companies

• Adelphi Healthcare Packaging
• Akorn, Inc.
• Alcami Corporation, Inc.
• Ardena Holding NV
• Becton, Dickinson and Company
• Berkshire Sterile Manufacturing
• Baxter International Inc.
• Berry Global Inc.
• Catalent Inc.
• Gerresheimer AG.
• Nipro Corporation
• PCI Pharma Services
• Schott AG
• SGD Pharma
• SiO2 Materials Science.
• Stevanato Group S.p.A
• Terumo Corporation
• UDG Healthcare Plc.
• West Pharmaceutical Services, Inc.
• Ypsomed Holding AG

Segments Covered in the Report

By Products

• Bottles
• Ampoules
• Vials
• Prefilled Syringes
• Cartridges
• Others

By Drug

• Small Molecules
• Biologics
• Vaccines
• Biosimilars
• Others

By Material

• Glass
• Polymer
• PVC
• Others

By Packaging

• Small Volume Parenteral
• Large Volume Parenteral

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa